Form 8-K
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 25, 2011
SELECT MEDICAL HOLDINGS CORPORATION
SELECT MEDICAL CORPORATION
(Exact name of registrant as specified in its charter)
         
Delaware
Delaware 		  001-34465
001-31441 		  20-1764048
23-2872718
         
(State or other jurisdiction
of incorporation) 		  (Commission File Number)   (IRS Employer Identification No.)
     
4714 Gettysburg Road, P.O. Box 2034
Mechanicsburg, PA 		   
17055
     
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code: (717) 972-1100
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

Item 8.01   Other Events
On April 25, 2011, Select Medical Holdings Corporation issued a press release announcing that Select Medical Corporation had commenced a cash tender offer for any and all of its $611,500,000 aggregate principal amount of 75/8% Senior Subordinated Notes due 2015 (the “Notes”) and a related consent solicitation to amend the indenture relating to the Notes. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01   Financial Statements and Exhibits.
(d) Exhibits.
     
Exhibit Number   Description
 
    
99.1
  Press Release, dated April 25, 2011, announcing commencement of tender offer for 75/8 % Senior Subordinated Notes due 2015.

 

 

 

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
         
  SELECT MEDICAL HOLDINGS CORPORATION
SELECT MEDICAL CORPORATION
 		  
Date: April 25, 2011  By:   /s/ Michael E. Tarvin    
    Michael E. Tarvin   
    Executive Vice President, General Counsel and Secretary   

 

 

 

         
EXHIBIT INDEX
     
Exhibit Number   Description
99.1
  Press Release, dated April 25, 2011, announcing commencement of tender offer for 75/8% Senior Subordinated Notes due 2015.